JPMorgan Double Upgrades Clorox (CLX) to Overweight; Sees Upside to Estimates on COVID-19 Demand
Go back to JPMorgan Double Upgrades Clorox (CLX) to Overweight; Sees Upside to Estimates on COVID-19 Demand| The Clorox Company (NYSE: CLX) | Delayed: 106.54 +0.78 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $105.76 | 52 Week High | $140.47 | |||
| Open | $106.13 | 52 Week Low | $111.24 | |||
| Day High | $107.45 | P/E | 24.83 | |||
| Day Low | $104.45 | EPS | $4.29 | |||
| Volume | 3,846,858 | |||||
